Carcinogenesis: Integrative Cancer Research is celebrating its 30 th Anniversary! The outstanding reviews in this anniversary issue of the journal provide informative snapshots of the field of cancer research. The reviews concisely present past and current research accomplishments and point to future directions.

The journal was co-founded by Colin Garner and Anthony Dipple, who wrote in 1980 “ Carcinogenesis ….will encourage a cross-fertilization of ideas, in addition to providing a primary literature source for the latest developments in this area…” of research. I am proud to continue their vision – still relevant to the success of the Journal today – since joining the Journal's editorial team in 1984.

The second milestone in the history of Carcinogenesis was its joining Oxford University Press. Guidance of Managing Editors initially by Martin Richardson, who is now the Managing Director, UK Academic and Journals Division, and more recently by Janet Boullin, Mandy Hill, Claire Bird, Julia Jeans and Phil Bishop has also significantly contributed to the development of the Journal. While their colleagues in sales and marketing, among them Charlotte Capanni, Amanda Hirko, and most recently Erin Ganley, have ensured that the research community is aware of the Journal.

The third milestone was the impact of the internet on the journal. This has allowed online submission of manuscripts, and their rapid review and electronic publishing. Carcinogenesis is one of the few journals in the field of cancer research that does not apply page charges, has an average review time to first decision of three weeks, and publishes accepted manuscripts online within one week of acceptance on average (through the ‘Advance Access’ facility). Authors can also choose to publish their work under an optional ‘open access’ model ( ). Research published in Carcinogenesis is now immediately available to more than 4,500 institutions with online access, in more than 1,000 institutions through the Developing Countries initiative of Oxford University Press.

The increasing stature of the Journal has lead to many more submissions and necessitated the addition of more Editors. In 1996, Professor Allan Balmain, with the assistance of Dr Robert Brown, succeeded Professor R. Colin Garner, who stepped down after 17 years’ service to the Journal. In 2003, Dr Roger Reddel (Cancer Biology), Dr Manuel Serrano (Carcinogenesis), Dr Chung S. Yang (Chemoprevention) joined as Editors, and the current Editors are Alan Clarke (since 2006), Thomas Kensler and Takashi Takahashi (since 2007). I sincerely thank my colleagues for their service to the Journal and the scientific community. We also have an outstanding Editorial Board, who with a large number of referees, critically and rapidly review the submitted reports. We welcome new Editorial Board members who begin their 3-year terms in January 2010: Drs David Beer, Zigang Dong, Thomas Helleday, Perwez Hussain, David Livingston, Maureen Murphy, Yusuke Nakamura, Thomas Ried, Matthew Schabath, Yu Shyr, Nanjoo Suh, Michael Wargovich and Qimin Zhan. We also thank those who rotate off the board including Drs Bruno Amati, Mariano Barbacid, Sandy Chang, Lawrence Donehower, David Hunter, Suet Yi Leung, Gerd Pfeifer, Ranju Ralhan, Daniel Rosenberg, Varda Rotter, Luisa Lina Villa, Chris Wild and Chung S Yang.

In the early years of the Journal, the Editorial Office was managed by Elizabeth Green with Verity Powell's capable support at Oxford Journals, but since 2006 the Editors have sincerely appreciated the dedication and expertise of Penny Brown in the efficient running of the Carcinogenesis Editorial Office. She is joined by a highly skilled and professional team at Oxford Journals, particularly Phil Bishop, Radha Dutia and Erin Ganley, who provide invaluable support and advice.